Xvivo Perfusion AB (OSTO:XVIVO) Days Sales Outstanding : 65.42 (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Xvivo Perfusion AB Days Sales Outstanding?

Xvivo Perfusion AB's average Accounts Receivable for the three months ended in Mar. 2024 was kr133.4 Mil. Xvivo Perfusion AB's Revenue for the three months ended in Mar. 2024 was kr186.0 Mil. Hence, Xvivo Perfusion AB's Days Sales Outstanding for the three months ended in Mar. 2024 was 65.42.

The historical rank and industry rank for Xvivo Perfusion AB's Days Sales Outstanding or its related term are showing as below:

OSTO:XVIVO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.47 Med: 64.37 Max: 85.14
Current: 75.98

During the past 12 years, Xvivo Perfusion AB's highest Days Sales Outstanding was 85.14. The lowest was 42.47. And the median was 64.37.

OSTO:XVIVO's Days Sales Outstanding is ranked worse than
62.95% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 63.94 vs OSTO:XVIVO: 75.98

Xvivo Perfusion AB's Days Sales Outstanding declined from Mar. 2023 (73.60) to Mar. 2024 (65.42).

Xvivo Perfusion AB Days Sales Outstanding Historical Data

The historical data trend for Xvivo Perfusion AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB Days Sales Outstanding Chart

Xvivo Perfusion AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

72.26

85.14

65.13

64.40

58.83

Xvivo Perfusion AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															73.60	79.31	84.05	67.93	65.42

Competitive Comparison of Xvivo Perfusion AB's Days Sales Outstanding

For the Medical Devices subindustry, Xvivo Perfusion AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xvivo Perfusion AB's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Xvivo Perfusion AB's Days Sales Outstanding falls into.

Xvivo Perfusion AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Xvivo Perfusion AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (94.5	+	98.127)	/	2 )	/	597.542	*	365
=	96.3135					/	597.542	*	365
=	58.83

Xvivo Perfusion AB's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (98.127	+	168.603)	/	2 )	/	186.022	*	365 / 4
=	133.365					/	186.022	*	365 / 4
=	65.42

Xvivo Perfusion AB (OSTO:XVIVO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Xvivo Perfusion AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Xvivo Perfusion AB (OSTO:XVIVO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (OSTO:XVIVO) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

XVIPF:USA 3XV:Germany

Address

Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14

Website

https://www.xvivoperfusion.com

Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB (OSTO:XVIVO) Headlines

No Headlines